Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven
scientific article published on February 2013
Author/s
author: Graeme J. Hankey, Scott D Berkowitz, Robert Califf, Kenneth W Mahaffey, Jonathan P. Piccini, Jonathan L. Halperin, Günter Breithardt, Yuliya Lokhnygina, Daniel E. Singer, Richard C Becker, Manesh Patel, Keith Fox, Christopher C Nessel, Anne S Hellkamp, Werner Hacke
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.